Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms
  • CME
  • CE

Credits Available
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Registered Nurses: 0.5 Nursing contact hours
Released: August 27, 2021 Expiration: August 26, 2022
Start Activity
Provided by Consortium of Multiple Sclerosis Centers (CMSC), in collaboration with Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Biogen
Bristol-Myers Squibb
Patricia K. Coyle, MD, FAAN, FANA
Patricia Melville, ANP-BC, MSCN

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Adopt best practices in recognizing and managing comorbidities in patients with MS
  • Discuss the influence of comorbidities on MS treatment outcomes

Information on this Educational Activity

In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC is committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

The program faculty reported the following relevant financial relationships that they have with ineligible companies:

Faculty

Patricia K. Coyle, MD, FAAN, FANA

Professor and Vice Chair (Clinical Affairs)
Director, MS Comprehensive Care Center
Department of Neurology
Stony Brook University Hospital
Stony Brook, New York

Patricia K. Coyle, MD, FAAN, FANA, has disclosed that she has received consulting fees from Accordant, Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, EMD Serono, Genentech/Roche, GlaxoSmithKline, Janssen, Mylan, Novartis, Sanofi Genzyme, TG Therapeutics, and Viela Bio; funds for research support from Alkermes, Corrona, Genentech/Roche, MedDay, and NINDS; and fees for non-CME/CE services from Biogen and Janssen.
Patricia Melville, ANP-BC, MSCN

Clinical Instructor
Neurology/MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York

Patricia Melville, ANP-BC, MSCN, has disclosed that she has received consulting fees from Alexion, Biogen, Celgene/Bristol-Myers Squibb, Genentech, and Sanofi Genzyme and fees for non-CME/CE services from Alexion, Biogen, Celgene/Bristol-Myers Squibb, Genentech, Novartis, and Sanofi Genzyme.

The planners, content developers, reviewers, and other staff at Clinical Care Options, LLC and CMSC have disclosed no relevant financial relationships.

All of the relevant financial relationships listed for these individuals have been mitigated

Disclosure of Unlabeled Use

CMSC and Clinical Care Options, LLC require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Disclaimer

CMSC and Clinical Care Options, LLC present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC and Clinical Care Options, LLC, and the commercial supporter(s) assume no liability for the information herein.

Target Audience

This program is intended for neurologists, primary care physicians, nurse practitioners, nurses, and other healthcare providers who care for patients with MS.

Goal

The goal of this activity is to improve the knowledge and competence of learners to recognize and manage comorbidities and MS symptoms in patients with MS.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and the {joint provider}. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

The Consortium of Multiple Sclerosis Centers designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The Consortium of Multiple Sclerosis Centers designates this enduring material for 0.5 contact hours of nursing continuing professional development.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 27, 2021, through August 26, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms
  • CME
  • CE

Loading...
In this concise Medical Minute video, experts discuss the clinical implications of sleep disorders and obesity for patients with MS and offer evidence-based recommendations for proper treatment.
Patricia K. Coyle, MD, FAAN, FANA
Patricia Melville, ANP-BC, MSCN
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Registered Nurses: 0.5 Nursing contact hours
Released: August 27, 2021 Expiration: August 26, 2022

Related Content

Dr Stuart H. Isaacson presents Parkinson disease today: managing off symptoms, from Clinical Care Options (CCO)

Stuart Isaacson, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit Released: January 18, 2022 Expired: January 17, 2023

Slides from a presentation that educates clinicians on the pharmacotherapy of antipsychotic-induced movement disorders.

Jonathan M. Meyer, MD Released: December 8, 2021

Access this medications glossary for a list of common psychiatric medications.

Released: December 8, 2021

Dr Greg Mattingly reviews the latest available clinical data for emerging diagnostic and therapy options for managing the mood disorders and TD, from Clinical Care Options (CCO)

Greg Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: November 22, 2021 Expired: November 21, 2022
Provided by Consortium of Multiple Sclerosis Centers (CMSC), in collaboration with Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Biogen
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings